Aprea Therapeutics, Inc. (APRE)
0.69
+0.07
(+10.51%)
USD |
NASDAQ |
Feb 06, 16:00
0.6505
-0.04
(-5.72%)
After-Hours: 20:00
Aprea Therapeutics EPS Diluted (Quarterly) : -0.4664 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.972M |
| Revenue (Quarterly) | 0.0018M |
| Total Expenses (Quarterly) | 2.974M |
| Enterprise Value | -8.636M |
| Gross Profit Margin (Quarterly) | -200.0% |
| Profit Margin (Quarterly) | -165.1K% |
| Earnings Yield | -310.3% |
| Normalized Earnings Yield | -310.29 |